Harnessing the Power of the Cre-loxP System: Benefits, Challenges, and Applications
Registration link:
Dates:
Wednesday, Nov. 20th, 2024; 11:00 am PST, or 2:00 pm EST
Webinar Highlights:
This webinar will introduce the Cre-loxP system, a powerful genetic tool that has revolutionized biological research by allowing for conditional gene knockout, knockdown, and overexpression. We will cover the history of the genetic recombination systems, discuss how they enable precise control of gene expression in specific cell types or at specific developmental stages, and present GenoBioTX’s genetically modified models utilizing this method.
Meet Our Speaker:
Dr. Andrei E. Golovko received Master of Science in Microbiology at Moscow State University in 1992, MBA in Marketing at Rutgers University, Newark, NJ in 2001, and PhD at The Institute of Cell Biology and Genetic Engineering, Kiev, Ukraine in 2003. Dr. Andrei E. Golovko has more than 29 years of experience in genetics, genomics, comparative medicine and disease modeling working in both industry and academic environment including BASF, Schering-Plough and Texas A&M. His demonstrated success in knockout mouse production includes designing, creating and analyzing genetically modified mice carrying null mutations for various potential drug targets including NPC1L1, the proven target for Schering's multibillion-dollar drug Zetia. At present time he serves Associate Director Business Development .
About GenoBioTX
GenoBioTX provides comprehensive animal modeling services, ranging from model construction to preclinical in vitro and in vivo assays, based on the combination of versatile technical platforms and experienced scientist.
Contact us
Website: www.genobiotx.com
Email: info@genobiotx.com
Address: 10410 Corporate Dr., Sugar Land, TX, 77478, USA
You may also like
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
Learn moreSMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
Learn more
